Mayo Clinic Talks Episode 86: Getting the Most Out of Colon Cancer Screening
Mayo Clinic Talks Podcast
Mayo Clinic Employees - no charge. Login with your Mayo Clinic email to access this offer.
John B. Kisiel, M.D.
|Who is a good candidate for multitarget stool DNA testing and what do you do when it’s positive but the colonoscopy is discordant? Do you have a surveillance plan for your patients with ulcerative colitis and irritable bowel disease? What are the current screening recommendations for the general public versus patients with a family history? Dr. John Kisiel discusses these recommendations and the evidence behind them. He shares tips on managing patients on anticoagulant therapy going for polypectomy and when to stop screening in the elderly.|
This course is intended for primary care providers: physicians, nurse practitioners, and physician assistants
Upon completion of the Mayo Clinic Talks Podcast course, learners should be able to:
- Describe the current treatment recommendations for patients with hyperlipidemia.
- List the various categories of hypertension.
- Describe the current pharmacologic treatment available for patients with osteoporosis.
Participation in this Mayo Clinic online course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Attendance